Investigating status of tumorigenic barriers in monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM)
Master's
Saved in:
Main Author: | ZAHRA KABIRI |
---|---|
Other Authors: | PATHOLOGY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/17281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
by: Girard, Louis-Pierre, et al.
Published: (2022) -
Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
by: Chng, W.-J., et al.
Published: (2014) -
Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges
by: Da, Yi, et al.
Published: (2022) -
Thyroid cytology—nuclear versus architectural atypia within the “Atypia of undetermined significance/follicular lesion of undetermined significance” Bethesda category have significantly different rates of malignancy
by: Gan T.R.X., et al.
Published: (2018) -
Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen
by: Theerawat Kumutpongpanich, et al.
Published: (2019)